In a note, RBC Capital Markets says the selloff in Mylan N.V. (MYL -2.3%), stoked by India’s three-week nationwide lockdown amid the COVID-19 pandemic, is overdone.
The company has substantial exposure in India,
about half of its manufacturing facilities are located there, but the
government considers drug-making facilities essential, exempting them
from the shutdown.
Mylan has confirmed that its operations there are continuing without significant disruption.
Shares are down ~36% since early February.
https://seekingalpha.com/news/3555174-selloff-in-mylan-over-india-exposure-overdone-rbc
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.